Telehealth General Psychiatry Prescribing: What Psychiatrists Can Do in Illinois

If you’re a psychiatrist or psychiatric nurse practitioner considering telehealth, you’ve probably asked yourself: Can I legally prescribe medications—especially controlled substances like stimulants or benzodiazepines—through a video visit?

The short answer: Yes, in most cases. But the longer answer involves navigating a patchwork of federal DEA rules and state-specific regulations that can vary dramatically depending on where your patient is located and what provider type you are.

This guide cuts through the confusion. We’ll walk through what psychiatrists and PMHNPs can prescribe via telehealth in 2026, how the rules differ by state (focusing on California, Texas, Florida, New York, Pennsylvania, and Illinois), and what you need to know about scope of practice, collaborative agreements, and reimbursement.

The Federal Landscape: DEA Waivers and Controlled Substance Prescribing

Before the COVID-19 pandemic, the Ryan Haight Act required prescribers to conduct at least one in-person medical evaluation before prescribing controlled substances (Schedule II–V drugs like Adderall, Xanax, or Suboxone). For psychiatrists managing ADHD, anxiety, or opioid use disorder, this was a significant barrier to telehealth.

In March 2020, the DEA waived this requirement under public health emergency powers. As of February 2026, that flexibility remains in effect—extended through December 31, 2025. This means psychiatrists nationwide can initiate controlled substance prescriptions via telehealth without an initial in-person visit, as long as the telehealth encounter meets the standard of care (typically a live audio-visual consultation).

What this means practically:

• A California psychiatrist can start a new ADHD patient on Adderall after a thorough video evaluation.
• A New York PMHNP (with appropriate state authority—more on that below) can prescribe benzodiazepines for anxiety via telehealth.
• A Texas psychiatrist can manage buprenorphine for opioid use disorder entirely online.

However, providers should stay alert: the DEA has proposed permanent rules that may reinstate some in-person requirements or impose 30-day supply limits for certain medications. The final rule is expected by late 2024 or early 2025. Until then, the current waiver applies.

State-level nuances matter too. While federal law sets the floor, some states have carved out specific exceptions or additional restrictions for teleprescribing controlled substances—especially for psychiatric vs. pain management treatment.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-Specific Prescribing Rules: What Psychiatrists Need to Know

California: Transitioning to Full NP Independence

Psychiatrists (MD/DO): Full independent prescribing authority. No restrictions on telehealth prescribing as long as a ‘good faith exam’ is conducted. California law explicitly allows telehealth exams to satisfy this requirement.

PMHNPs: California is in the middle of a major shift thanks to AB 890 (2020). As of 2023, experienced NPs (≥3 years post-graduation) can apply to become ‘103 NPs’—allowing them to practice in collaborative settings (clinics, group practices) without direct physician supervision. Starting January 1, 2026, these NPs can upgrade to ‘104 NP’ status, which grants full independent practice authority, including prescribing controlled substances without any physician involvement.

New graduate PMHNPs still need to work under a physician’s standardized procedure for their first three years, but the state is clearly moving toward parity between NPs and MDs.

Telehealth & Controlled Substances: No special state restrictions. Psychiatrists can prescribe Schedule II–V medications via telehealth under the federal DEA waiver. California requires checking the CURES (Prescription Drug Monitoring Program) before prescribing Schedule II–IV drugs—this applies to both in-person and telehealth visits.

Reimbursement: California law mandates payment parity for telehealth services for private insurers (since 2019), so psychiatrists are paid the same whether the visit is in-office or online.

Texas: Strict NP Supervision, But Telehealth Prescribing Allowed

Psychiatrists (MD/DO): Full independent authority. Texas psychiatrists can prescribe any psychiatric medication via telehealth, including controlled substances, as long as the encounter meets the standard of care (real-time audio-visual interaction).

PMHNPs: Texas is a restricted practice state. PMHNPs must have a Prescriptive Authority Agreement with a Texas-licensed physician to prescribe any medication. There is no pathway to independent practice, regardless of experience.

Key restrictions for Texas NPs:

• Cannot prescribe Schedule II controlled substances in most outpatient settings (exceptions exist for terminal illness or emergencies).
• In psychiatry, this means Texas PMHNPs generally cannot prescribe ADHD stimulants on their own. Many practices have the collaborating psychiatrist write the initial script, or the NP prescribes Schedule III–V alternatives (like Vyvanse, which is Schedule II, or non-controlled options).
• Must have monthly meetings with the supervising physician for the first three years, then quarterly.
• Physicians are capped at supervising 7 NPs/PAs at a time.

Telehealth & Controlled Substances: Texas allows teleprescribing of controlled substances for mental health treatment (e.g., benzodiazepines, stimulants) under the federal waiver. However, Texas prohibits teleprescribing Schedule II opioids for chronic pain management—an in-person visit is required for that use case. For psychiatric prescribing, this isn’t typically an issue.

Reimbursement: Texas has no mandated telehealth payment parity, but most major insurers voluntarily reimburse tele-mental health at the same rate as in-person due to high demand.

Bottom line for Texas: Psychiatrists have full freedom. PMHNPs face significant restrictions and must work under physician oversight, which can be a bottleneck for telehealth platforms looking to scale NP-driven care.

Florida: Psych NPs Excluded from Autonomous Practice (For Now)

Psychiatrists (MD/DO): Full independent authority. Florida is one of the few states that explicitly permits controlled substance prescribing via telehealth for psychiatric treatment in statute (F.S. 456.47). This carve-out was designed to ensure continuity of mental health care.

PMHNPs: Florida passed HB 607 (2020), creating an ‘Autonomous APRN’ category—but it only applies to primary care NPs (family medicine, pediatrics, internal medicine). Psychiatric NPs were excluded from this independence.

What this means:

• PMHNPs in Florida must still practice under a supervising physician’s protocol.
• To prescribe psychotropic controlled substances, the PMHNP must be designated as a ‘psychiatric nurse’ (MSN/DNP in psych + 2 years experience under a psychiatrist) and must have a psychiatrist as their collaborating physician.
• Schedule II prescriptions by NPs are capped at a 7-day supply, except for psychiatric nurses prescribing psychiatric medications—they are exempt from this limit.

Telehealth & Controlled Substances: Florida law allows controlled substance prescribing via telehealth for mental health treatment. However, out-of-state NPs registered to provide telehealth in Florida cannot prescribe controlled substances to Florida patients (only fully licensed providers can).

Reimbursement: No state parity mandate, but many insurers cover tele-mental health at parity voluntarily.

Bottom line for Florida: Psychiatrists have significant telehealth prescribing freedom. PMHNPs are restricted and must maintain a psychiatrist collaborator, limiting scalability for NP-driven telehealth.

New York: Experience-Based NP Independence

Psychiatrists (MD/DO): Full independent authority. New York recently aligned its state controlled-substance prescribing rules with federal DEA allowances (mid-2025), removing state-level barriers to teleprescribing controlled substances.

PMHNPs: New York uses a tiered approach. New NPs must practice under a written collaborative agreement with a physician (often a psychiatrist for PMHNPs) for their first 3,600 hours of practice (roughly 2 years full-time). After accumulating these hours and filing an attestation, they can practice independently—no written agreement or supervision required.

Experienced NY PMHNPs essentially have full practice authority. They must maintain a ‘collaborative relationship’ (informal physician contacts for referral/consultation), but there’s no chart review or oversight requirement.

Telehealth & Controlled Substances: New York’s 2025 regulations permit teleprescribing of controlled substances consistent with federal DEA waivers. Psychiatrists and experienced PMHNPs can initiate controlled meds via telehealth. New York requires e-prescribing for all controlled substances and mandates checking the I-STOP (NY’s PMP) before prescribing Schedule II–IV drugs.

Reimbursement: Strong telehealth support. All insurers must cover telehealth, and payment parity is effectively in place for behavioral health services.

Bottom line for New York: One of the most progressive states for PMHNPs. After two years of practice, NPs can operate like psychiatrists in terms of prescribing authority.

Pennsylvania: Ongoing Collaboration Required

Psychiatrists (MD/DO): Full independent authority.

PMHNPs: Pennsylvania requires NPs to maintain a collaborative agreement with a physician indefinitely—there is no pathway to independent practice as of 2026. Legislation to grant full practice authority has been introduced (e.g., SB 25 in 2021–22) but has not yet passed.

Key PA requirements for NPs:

• Must have a written collaborative agreement filed with the PA Board of Nursing.
• Can prescribe Schedule II–V controlled substances if delegated by the collaborating physician, but Schedule II prescriptions are limited to a 30-day supply and the physician must be notified within 24 hours.
• Physician must review a portion of the NP’s charts regularly (often 100% of Schedule II prescriptions).
• At least two face-to-face meetings per year with the collaborating physician to review the agreement.

Telehealth & Controlled Substances: No special state restrictions beyond federal law. PA Medicaid and major insurers cover telepsychiatry, but the state lacks a comprehensive telehealth parity statute (efforts ongoing).

Bottom line for Pennsylvania: PMHNPs can prescribe controlled substances but must work under physician oversight. This limits independent telehealth practice.

Illinois: 4,000-Hour Pathway to Independence

Psychiatrists (MD/DO): Full independent authority.

PMHNPs: Illinois allows NPs to apply for Full Practice Authority after completing 4,000 hours of clinical practice under physician collaboration plus 250 hours of continuing education in advanced pharmacology (effective 2018 via PA 100-513).

Until FPA is granted, Illinois NPs must have a Written Collaborative Agreement with a physician. Prescriptions must list the collaborating physician’s name (indicating it’s under delegation). Once the NP achieves FPA licensure, they can prescribe independently, including controlled substances (with their own mid-level controlled substance license).

Telehealth & Controlled Substances: Illinois enacted strong telehealth parity laws in 2021 (SB 667), requiring private insurers to reimburse telehealth services at parity through at least 2027 for behavioral health. Medicaid and commercial plans pay equally for telepsychiatry.

Illinois NPs with FPA can prescribe Schedule II–V controlled substances. One caveat: newly independent NPs cannot prescribe opioids for chronic pain management without physician consultation—but this is outside typical psychiatric prescribing.

Bottom line for Illinois: Progressive state with a clear pathway for PMHNPs to achieve independence after a few years. Strong telehealth support and reimbursement parity.

PMHNP vs. Psychiatrist Prescribing Authority: The Key Differences

Understanding the scope-of-practice gap between psychiatrists and PMHNPs is critical for compliance and practice planning:

Psychiatrists (MD/DO):

• Full independent prescribing authority in all 50 states.
• No collaborative agreements or supervision required.
• Can prescribe any psychiatric medication, including all Schedule II–V controlled substances, under their own DEA registration.

PMHNPs:

• Authority varies dramatically by state:
• Full Practice Authority states (~34 states as of 2025): NPs can practice and prescribe independently, including controlled substances. Examples: Washington, Oregon, Arizona, New Mexico, Colorado, Minnesota, Maryland, Massachusetts.
• Reduced Practice states: NPs need collaborative agreements with physicians, often with transition-to-independence pathways (e.g., New York after 3,600 hours, Illinois after 4,000 hours, California after 3 years).
• Restricted Practice states: NPs must work under continuous physician supervision or delegation indefinitely. Examples: Texas, Florida (for psych NPs), Pennsylvania, Tennessee, Alabama.

Collaborative Agreements (in reduced/restricted states) typically require:

• Written protocol specifying the NP’s scope and prescriptive authority.
• Regular physician chart review (e.g., 10% of charts monthly in some states).
• Periodic meetings between NP and physician.
• State board approval in some cases.

Reimbursement Differences:

• Medicare reimburses NPs at 85% of the physician fee schedule when billed under the NP’s own NPI.
• Some states (Nevada, Maryland) have passed equal reimbursement laws requiring insurers to pay NPs the same as MDs for the same service.
• Many private insurers pay NPs at 85–100% of physician rates, depending on the contract.

Medication Management Reimbursement: What to Expect in 2026

Psychiatrists and PMHNPs primarily bill Evaluation & Management (E/M) codes for medication management visits:

• CPT 90792 (initial psychiatric eval with med management, ~60 min): Medicare pays ~$173 in 2026.
• CPT 99213 (15-min follow-up, established patient): Medicare pays ~$95.
• CPT 99214 (25-min follow-up, moderate complexity): Medicare pays ~$136.

Private insurance often pays more—e.g., $150 for a 99213, $200 for a 99214 in high cost-of-living areas.

Telehealth Parity:

• Medicare permanently allows telehealth for mental health services (with a minor requirement of an in-person visit every 12 months, currently paused through 2025).
• Most states with telehealth parity laws apply them to behavioral health—psychiatrists are paid the same whether the visit is in-office or via video.
• Over 40 states have private insurance telehealth parity laws, and more than half include behavioral health.

Medicaid rates are typically lower than Medicare, but many state Medicaid programs have enhanced reimbursement for behavioral health or collaborative care models.

Audio-only telehealth: Medicare now reimburses certain mental health services delivered via audio-only phone at the same rate as video (important for populations lacking video access), extended through 2024.

The Economics of Patient Acquisition: Why Platforms Like Klarity Make Sense

Here’s the reality of building a psychiatric practice through traditional marketing:

DIY Marketing (SEO, Google Ads, Directories):

• True patient acquisition cost: $200–$500+ per booked patient when you factor in:
• Agency/consultant fees ($2,000–$5,000/month)
• Ad spend testing and optimization ($1,500–$3,000/month)
• Staff time to handle and qualify leads (15–30 hours/month)
• No-show rates from cold leads (30–40% in some markets)
• SEO investment timeline: 6–12 months before meaningful patient flow
• Google Ads for mental health: $15–$40+ per click; realistic cost per booked patient is $200–$400+ due to low conversion rates.
• Directory listings (Psychology Today, Zocdoc): Monthly subscription fees + per-booking charges. Zocdoc charges $35–$100+ per booking, plus monthly subscription. Psychology Today is $30–$40/month but you compete with hundreds of other providers on the same page.

The Hidden Costs:

• Most solo providers don’t have the expertise or patience to run effective SEO or PPC campaigns.
• Failed campaigns are common—you can easily burn $3,000–$5,000 testing ads before you find what works.
• Managing leads, responding to inquiries, and scheduling appointments takes significant staff time (or your time).

Klarity Health’s Model:Instead of gambling on marketing channels with uncertain ROI, Klarity uses a pay-per-appointment model similar to Zocdoc—but with key advantages:

• No upfront marketing spend or monthly subscription fees. You pay a standard listing fee only when a qualified patient books with you.
• Pre-qualified patients already matched to your specialty and availability. No wasted time on unqualified leads.
• No wasted ad spend on clicks that don’t convert. The platform handles patient acquisition end-to-end.
• Built-in telehealth infrastructure (no separate platform costs like Doxy.me or SimplePractice).
• Both insurance and cash-pay patient flow, depending on your preference.
• You control your schedule—only pay when you see patients. That’s guaranteed ROI vs. gambling on marketing.

Frame it this way: Instead of spending $3,000–$5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. The risk is removed entirely.

DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience—but for most providers, especially those starting out or scaling, a platform that handles patient acquisition removes the risk and lets you focus on what you do best: treating patients.

Staying Compliant: Documentation, Consent, and PMP Checks

Whether you’re a psychiatrist or PMHNP, here are the non-negotiables for telehealth prescribing:

1. Establish a valid patient-provider relationship: Conduct a thorough telehealth evaluation (typically video) that meets the same standard of care as an in-person visit. Verify patient identity and document the technology used.

2. Obtain consent for telehealth: Many states (e.g., Texas, California) require informing the patient of telehealth limitations and obtaining documented consent before treatment.

3. Check the Prescription Monitoring Program (PMP): Before prescribing controlled substances, check your state’s PMP (CURES in CA, I-STOP in NY, Texas PMP, etc.). Most states require this for Schedule II–IV drugs.

4. Document the encounter thoroughly: Include the patient’s mental status exam, rationale for prescribing (especially controlled substances), discussion of risks/benefits, and any coordination with the patient’s PCP. Note that the visit was conducted via telehealth and document the patient’s location.

5. Use e-prescribing: Many states (e.g., New York) require e-prescribing for controlled substances. Use a HIPAA-compliant e-prescribing system integrated with your EHR.

6. Stay updated on DEA rule changes: The current federal waiver allowing controlled-substance prescribing via telehealth is expected to be replaced by permanent rules in late 2024/early 2025. Subscribe to DEA updates or professional association newsletters to stay informed.

Frequently Asked Questions

Can psychiatrists prescribe Adderall or other ADHD stimulants via telehealth in 2026?Yes, in most states. Under the current federal DEA waiver (extended through December 31, 2025), psychiatrists can initiate Schedule II stimulants like Adderall, Ritalin, or Vyvanse via telehealth without an initial in-person visit, as long as the encounter meets the standard of care (typically a live video consultation). Some states like Texas prohibit teleprescribing Schedule II for chronic pain, but psychiatric treatment is exempt. Stay alert for DEA rule changes in late 2024.

Can PMHNPs prescribe controlled substances independently?It depends on the state. In Full Practice Authority states (e.g., Washington, Oregon, Arizona, Colorado, Minnesota, Maryland), PMHNPs can prescribe controlled substances independently with their own DEA license. In reduced/restricted states (e.g., Texas, Florida, Pennsylvania), PMHNPs need a collaborative agreement with a physician, and some states (like Texas) prohibit NPs from prescribing Schedule II controlled substances in most outpatient settings.

Do I need to see telehealth patients in person before prescribing medications?Not under current federal law (DEA waiver extended through December 31, 2025). However, some states have additional requirements. For example, New York’s regulations now align with federal allowances, and Florida explicitly permits controlled substance prescribing via telehealth for psychiatric treatment. Texas allows it for mental health but prohibits it for chronic pain management. Check your state’s specific telehealth prescribing laws.

How do reimbursement rates compare for telehealth vs. in-person visits?For psychiatry, reimbursement is generally at parity. Medicare and most private insurers pay the same for telehealth mental health visits as in-person visits, thanks to telehealth parity laws and federal policies. Medicare pays approximately $95 for a 15-minute med check (99213) and $136 for a 25-minute visit (99214) in 2026, whether conducted in-office or via video. Over 40 states have private insurance telehealth parity laws, and more than half include behavioral health.

What’s the difference between a psychiatrist and a PMHNP in terms of prescribing authority?Psychiatrists (MD/DO) have full independent prescribing authority in all 50 states, including all Schedule II–V controlled substances. PMHNPs’ authority varies by state—about half of U.S. states grant full practice authority (independent prescribing), while others require collaborative agreements with physicians. In restrictive states like Texas and Florida, PMHNPs face significant limitations on what they can prescribe and must work under physician supervision.

Can I prescribe buprenorphine (Suboxone) for opioid use disorder via telehealth?Yes. The federal waiver (extended through December 31, 2025) allows psychiatrists and qualified PMHNPs to prescribe buprenorphine via telehealth without an initial in-person visit. The X-waiver requirement was eliminated in 2023, so any provider with a DEA license can now prescribe buprenorphine for opioid use disorder (though training is recommended). State laws vary—ensure you’re licensed in the patient’s state and follow any state-specific buprenorphine regulations.

What are the biggest compliance risks for telehealth prescribing?Key risks include: (1) Failing to check the state Prescription Monitoring Program (PMP) before prescribing controlled substances; (2) Prescribing to patients in states where you’re not licensed; (3) Not obtaining proper telehealth consent; (4) Inadequate documentation of the clinical encounter (especially for controlled substances); (5) Violating state-specific telehealth or controlled-substance prescribing laws (e.g., Texas’s prohibition on tele-prescribing Schedule II for chronic pain). Always verify you’re following both federal DEA rules and the specific laws of the state where the patient is located.

Next Steps: Join Klarity Health’s Provider Network

If you’re ready to grow your psychiatric practice without the headache of DIY marketing or the overhead of traditional practice management, Klarity Health offers a turnkey solution:

• Pre-qualified patients matched to your specialty (ADHD, anxiety, depression, medication management).
• Pay only when you see patients—no monthly fees or upfront marketing spend.
• Built-in telehealth platform with HIPAA-compliant video, e-prescribing, and EHR integration.
• Both insurance and cash-pay options, depending on your preference.
• Compliance support to help you navigate state licensing, PMP checks, and telehealth regulations.
• You control your schedule—see patients when and where you want.

Whether you’re a psychiatrist looking to add telehealth income streams or a PMHNP expanding into a new state, Klarity removes the patient acquisition risk and lets you focus on what you do best: providing high-quality psychiatric care.

Ready to learn more? Visit Klarity Health’s provider portal to explore the platform, review patient volume projections for your state and specialty, and take the first step toward a more flexible, scalable practice.

Sources and References

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship